Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

Graft-versus-host disease (GVHD) is a principal cause of morbidity following allogeneic hematopoietic cell transplantation (HCT). Standard therapy for GVHD, high-dose steroids, results in complete responses (CRs) in 35% of patients. Because tumor necrosis factor-α (TNFα) is an important effector of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Levine, John E., Paczesny, Sophie, Mineishi, Shin, Braun, Thomas, Choi, Sung W., Hutchinson, Raymond J., Jones, Dawn, Khaled, Yasser, Kitko, Carrie L., Bickley, Daniel, Krijanovski, Oleg, Reddy, Pavan, Yanik, Gregory, Ferrara, James L. M.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2008
Teme:
Transplantation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361693/
https://ncbi.nlm.nih.gov/pubmed/18042798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-09-112987
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items